Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

5.1%

2 terminated/withdrawn out of 39 trials

Success Rate

90.9%

+4.4% vs industry average

Late-Stage Pipeline

0 trials in Phase 3/4

Results Transparency

35%

7 of 20 completed trials have results

Key Signals

9 recruiting7 with results

Enrollment Performance

Analytics

N/A

29(85.3%)

Phase 2

3(8.8%)

Phase 1

2(5.9%)

34Total

N/A(29)

Phase 2(3)

Phase 1(2)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (39)

Showing 20 of 39 trials

NCT05176860Not ApplicableCompleted

Evaluation of Novel Cone-Beam CT for Guidance and Adaptation of Precision Radiotherapy

Role: lead

NCT06576908Not ApplicableCompleted

Evaluation of On-Couch CBCT Image Quality

Role: lead

NCT07413523Not ApplicableRecruiting

Randomized Trial of stAndard of Care With or Without Metastases-directed Stereotactic Body Radiation Therapy in Patients Affected by Oligometastatic uRothelial carcinomA

Role: collaborator

NCT05765175Not ApplicableRecruiting

Cardiac RADIoablation Versus Repeat Catheter Ablation: a Pivotal Randomized Clinical Trial Evaluating Safety and Efficacy for Patients With High-risk Refractory Ventricular Tachycardia (RADIATE-VT)

Role: lead

NCT06187103Active Not Recruiting

Evaluation of Improved Onboard Patient Imaging

Role: lead

NCT05700227Not ApplicableTerminated

Daily Online Adaptive Short-Course Radiation Therapy and Concurrent Chemotherapy for Muscle-Invasive Bladder Cancer

Role: lead

NCT05410509Not ApplicableCompleted

"Embolization Before Ablation of Renal Cell Carcinoma (EMBARC)"

Role: collaborator

NCT07354594Phase 2Not Yet Recruiting

External Beam and Radioligand Radiotherapy for mCRPC